Vonoprazan Tablets 20 Mg – Voprexia 20 Tablets

Voprexia 20 Tablets
Composition:- Vonoprazan 20 mg

Voprexia 20 Tablets – Vonoprazan Tablets 20 mg, a formulation of Wonne International Pvt. ltd., is a novel Potassium-Competitive Acid Blocker (P-CAB) formulated for the management of acid-related gastrointestinal disorders. It provides rapid, potent, and sustained suppression of gastric acid secretion by competitively blocking potassium binding at the H⁺/K⁺-ATPase enzyme system in gastric parietal cells.
Unlike conventional proton pump inhibitors (PPIs), vonoprazan offers a faster onset of action, stronger acid control, and consistent 24-hour suppression, making it highly effective in chronic conditions such as GERD, erosive esophagitis, and H. pylori eradication.

Key Points of Vonoprazan Tablets 20 Mg – Voprexia 20 Tablets
• Rapid Onset of Action: Offers effective acid suppression from the first dose of Vonoprazan Tablets 20 mg.
• Superior Acid Control: Provides stronger and more sustained gastric pH control compared to traditional PPIs.
• Once-Daily Convenience: 24-hour acid suppression enhances patient compliance.
• Effective in PPI-Resistant Cases: Demonstrates improved healing rates in refractory GERD.
• Useful in H. pylori Therapy: It enhances the eradication rates when combined with appropriate antibiotics.

Can be Prescribed by:
• General Physician
• Gastroenterologist
• Healthcare practitioner

Disclaimer: To be used strictly under the guidance of a qualified healthcare professional. For prescription use only. Not intended for public marketing or promotion.